Surprisingly, the combination of 50 nm dasatinib and 5 μm U0126 showed only mild synergistic effect and resulted in a decrease of approximately 75% in the colony formation ability of CML CD34+ cells (Fig. 4D). Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.